Latest Breaking News On - Neurocrine biosciences - Page 4 : comparemela.com

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Down 5 3%

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) were down 5.3% on Wednesday . The stock traded as low as $132.58 and last traded at $133.02. Approximately 153,432 shares were traded during trading, a decline of 81% from the average daily volume of 812,679 shares. The stock had previously closed at $140.48. Analyst […]

United statesMatt abernethyNeurocrine biosciencesMather groupFinancial groupLindbrook capitalEdgerock capitalCanaccord genuity groupNeurocrine biosciences incGet free reportDirector shalini sharpNeurocrine biosciences daily

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesMichel vounatsosSosei heptaresNeurocrine biosciencesKyle ganoChris viehbacherNxera pharmaKevin gormanTanabe pharmaXenon pharmaceuticalsDiurnal groupNeurocrine biosciencesEffective octoberWall streetNorth americanMitsubishi tanabe pharma

Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024

Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNeurocrine biosciencesRichard auchusDiurnal ltdEndocrine society annual meetingDrug administrationExchange commissionDiurnal groupNeurocrine biosciences incEuropean unionRegulatory agencyEuropean commissionAdult phaseStudy dataCongenital adrenal

Neurocrine Biosciences Announces CEO Succession Plan

Neurocrine Biosciences Announces CEO Succession Plan
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKyle ganoLos angelesTanabe pharmaWilliamh rastetterNeurocrine biosciencesKylew ganoKevin gormanNxera pharmaSosei heptaresNeurocrine biosciences incUniversity of oregonFranchise teamEuropean unionIdorsia ltd

Westfield Capital Management Co LP Sells 54,855 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)

Westfield Capital Management Co. LP decreased its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 8.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 594,437 shares of the company’s stock after selling 54,855 shares during the period. Westfield Capital Management Co. LP […]

United statesNeurocrine biosciencesMatt abernethyEnvestnet portfolio solutions incNeurocrine biosciences incFirst horizon advisors incSecurities exchange commissionSunbelt securities incCanaccord genuity groupWestfield capital management coQuadrant capital groupNeurocrine biosciences company profileWestfield capital managementFree reportCapital managementHorizon advisors